For 2022, R1 RCM Inc. announced that the company expects to generate: Revenue of between $1,790 million and $1,800 million and GAAP operating loss of $8 million to $13 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.06 USD | -0.82% | -2.72% | +15.04% |
16/05 | Transcript : R1 RCM Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 08:00 AM | |
14/05 | Deutsche Bank Adjusts R1 RCM Price Target to $14 From $15, Maintains Hold Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.04% | 5.12B | |
+15.87% | 83.4B | |
-27.67% | 72.11B | |
0.00% | 27.04B | |
-12.84% | 16.96B | |
+1.03% | 16.86B | |
+2.40% | 15.76B | |
+70.80% | 13.33B | |
+1.70% | 12.76B | |
+70.44% | 12.74B |
- Stock Market
- Equities
- RCM Stock
- News R1 RCM Inc.
- R1 RCM Inc. Provides Earnings Guidance for the Year 2022